Dual antiplatelet therapy is superior to aspirin in preventing short-term recurrent stroke at the cost of more major bleeding

Dual antiplatelet therapy is superior to aspirin in preventing short-term recurrent stroke at the cost of more major bleeding is a topic covered in the EE+ POEM Archive.

To view the entire topic, please or .

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

There's more to see -- the rest of this entry is available only to subscribers.